Veradermics MANE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$27.23M— | —— | —— | —— | -$12.4M-87.3% | ||
| $5.26M— | —— | —— | —— | $213K+241% | ||
| -$21.17M— | —— | —— | —— | -$13.32M-125% | ||
| $0— | —— | —— | —— | $19K— | ||
| -$101.3M— | —— | —— | —— | -$15.75M— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $269.11M— | —— | —— | —— | $8.42M-44.3% | ||
| $146.65M— | —— | —— | —— | -$20.64M-324% | ||
| -$21.17M— | —— | —— | —— | -$13.34M-125% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Veradermics generate?
- Veradermics (MANE) generated -$46.3M in operating cash flow over the trailing twelve months.
- What is Veradermics 's free cash flow?
- After $19.0K of capital expenditures, Veradermics 's free cash flow was -$46.3M over the trailing twelve months.
- Where does Veradermics 's cash flow data come from?
- Every line is extracted from Veradermics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.